ArticleCardiology and cardiovascular medicine2025
Interaction between Perivascular and Luminal Factors in Arteriovenous Fistula in Yucatan Miniswine.
Article in Cardiology and cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Arteriovenous fistula (AVF) is created in end-stage renal disease patients for hemodialysis. AVF maturation failure is a common complication due to thrombosis and stenosis of the vessels involved in AVF. Chronic inflammation along with perivascular cuffing plays a critical role in AVF maturation failure. Luminal as well as periluminal factors with the involvement of transcription and epigenetic factors play a critical role in AVF maturation failure. Our previous study reported MYOD1, a factor associated with muscle regeneration and increased with muscle injury, as a significantly increased transcription factor in AVF arteries compared to control. This study aims to characterize the perivascular and vascular AVF tissues for the expression of MYOD1, mediators of inflammation, immune cell markers, and apoptosis markers with the hypothesis that muscle injury mediates the recruitment of immune cells and activation of apoptosis leading to increased apoptosis and vascular thrombosis and fibrosis of perivascular structures. Previously collected tissues from Yucatan miniswine were stained and analyzed, and the results revealed increased expression of mediators of inflammation, immune cell markers, and apoptosis markers in association with increased MYOD1 expression. The findings suggest an interaction between the expression of perivascular factors and luminal factors, but further investigations using in-vitro studies are needed to establish this relationship.
Indexed as
Identifiers
40606544PMC12220929What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.